As of 2025-07-12, the Relative Valuation of Jounce Therapeutics Inc (JNCE) is (11.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.88 USD, the upside of Jounce Therapeutics Inc based on Relative Valuation is -702.0%.
The range of the Relative Valuation is (11.94) - (11.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 11.8x | 9.2x |
| Forward P/E multiples | 12.3x - 17.6x | 14.2x |
| Fair Price | (11.94) - (11.45) | (11.32) |
| Upside | -735.0% - -709.2% | -702.0% |
| Date | P/E |